Consensus guidelines define orthostatic disorders in adults on the basis of expert opinion and randomized controlled studies. 1 -3 These conclusions incompletely extend to children, for whom large trials and even small controlled studies are sparse. Pediatric orthostatic intolerance (OI) has drawn increasing attention in recent publications from different groups with different perspectives. 4 -7 The high and possibly increasing prevalence of orthostatic disorders in teenagers prompted the American Autonomic Society to convene member experts to draft an evidence-based State of the Art document. This document is intended to provide common ground on which to build a better understanding of pathophysiology and treatment.
The Challenge of orThosTasis (sTanding UprighT)
Humans are bipedal. While upright, our brain is above our heart, whereas 70% of our blood volume is below the heart. If not for autonomic and cardiovascular compensatory mechanisms, hypotension and loss of consciousness would ensue after orthostasis.
orthostatic intolerance
OI can be defined as having difficulty tolerating the upright posture because of symptoms that abate Orthostatic intolerance (OI), having difficulty tolerating an upright posture because of symptoms or signs that abate when returned to supine, is common in pediatrics. For example, ∼40% of people faint during their lives, half of whom faint during adolescence, and the peak age for first faint is 15 years. Because of this, we describe the most common forms of OI in pediatrics and distinguish between chronic and acute OI. These common forms of OI include initial orthostatic hypotension (which is a frequently seen benign condition in youngsters), true orthostatic hypotension (both neurogenic and nonneurogenic), vasovagal syncope, and postural tachycardia syndrome. We also describe the influences of chronic bed rest and rapid weight loss as aggravating factors and causes of OI. Presenting signs and symptoms are discussed as well as patient evaluation and testing modalities. Putative causes of OI, such as gravitational and exercise deconditioning, immune-mediated disease, mast cell activation, and central hypovolemia, are described as well as frequent comorbidities, such as joint hypermobility, anxiety, and gastrointestinal issues. The medical management of OI is considered, which includes both nonpharmacologic and pharmacologic approaches. Finally, we discuss the prognosis and long-term implications of OI and indicate future directions for research and patient management.
when returned to supine. Typical symptoms include a sense of impending loss of consciousness, cognitive deficits (memory loss and decreased reasoning and concentration), visual difficulties, lightheadedness, headache, fatigue, weakness, nausea, abdominal discomfort, tremulousness, exercise intolerance, and reported signs such as pallor, diaphoresis, tachycardia, bradycardia, or hypotension.
This definition encompasses all forms of orthostatic disorders, such as postural faint and orthostatic hypotension (OH), but not others, such as a broken leg or overt muscle disease. The definition is sufficiently broad to encompass postural vertigo, balance issues, and positional headache.
Chronic OI is defined as OI that is present for at least 3 months, although symptoms may wax and wane. An example is postural tachycardia syndrome (POTS).
Acute and subacute OI are defined as OI that has been present for <1 week and <3 months, respectively, or is restricted to recurrent episodes, such as with postural vasovagal syncope (VVS).
Some OI represents an extension of normal physiology, such as transient lightheadedness immediately on standing. Some consider infrequent VVS to be a normal response to central hypovolemia because its lifetime incidence approaches 40%, and it can be universally induced with sufficient orthostatic provocation. 2 However, OI that importantly diminishes quality of life deserves treatment.
In what follows, we more specifically define individual entities comprising OI and discuss how best to test for and diagnose OI. We review the epidemiology, predisposing factors, putative causes, and frequent comorbidities of OI and focus on POTS. We discuss management, prognosis, and future directions for research and therapy.
individUal enTiTies initial orthostatic hypotension
On standing, there is symptomatic hypotension because of the caudal transference of blood because of gravity and a time delay in sympathetic activation. 8 Blood pressure (BP) can decrease by >30%, reaching a nadir at 10 to 15 seconds after standing. Lightheadedness and reflex tachycardia occur. BP is restored within 30 seconds, but cerebral blood flow and heart rate (HR) take longer. 9 -11 Clinically significant initial orthostatic hypotension (IOH) is defined as a decrease in systolic BP of >40 mm Hg or a decrease in diastolic BP of >20 mm Hg. 10 The fall in BP is enhanced by the duration of the previous supine position. A history of transient lightheadedness dissipating in <1 minute should be considered as IOH. 7, 10, 12 Syncope is uncommonly reported with IOH. Countermeasures to obviate symptoms include active contraction of lower-body muscles or recumbence. 9, 10 IOH is the most common form of OI. 9, 12, 13 A representative standing test in which IOH is experienced is shown in Fig 1. OH is defined by the steady decrease in BP exceeding 20 mm Hg systolic or 10 mm Hg diastolic within 3 minutes of standing from supine. 1 
MoniToring dUring orThosTaTiC TesTing
The minimum requirement is an intermittent measurement of HR and BP. Current US Current Procedural Terminology codes require the measurement of beat-to-beat electrocardiogram and BP. 9, 12, 13 Automated autonomic testing is not validated and is not recommended for diagnoses. 44 Other monitoring uses nasal capnography, EEG, cerebral blood flow, or cerebral oximetry. Research measurements include regional blood flow and blood volume, pneumotachography, microneurography, and combined modalities.
prevalenCe and phenoType of pediaTriC poTs
The prevalence of POTS is not well established. 45 Its incidence in pediatrics is not known because screening for OI is not routine. OI affects a broad range of organ systems. Examples of common signs and symptoms are shown in Table 1 . 
CoMorbidiTies in pediaTriC oi
Several conditions are associated with pediatric OI, including joint hypermobility, functional gastrointestinal disorders (functional abdominal pain, nausea, and cyclic vomiting syndrome), chronic fatigue syndrome, headache, sleep disorders, cognitive dysfunction (brain fog), anxiety, and depression. Comorbidity does not signify direct causation. 81 Most researchers evaluate comorbidities in POTS; few address OH and VVS.
Joint hypermobility is associated with POTS, syncope, presyncope, fatigue, heat intolerance, and abnormal autonomic testing scores. 82 -85 Chronic pain and joint hypermobility are equally present in patients with POTS versus those without. 81 Functional gastrointestinal disorders are associated with autonomic dysfunction. 86 -88 POTS is associated with upper-gastrointestinal symptoms and antroduodenal dysmotility, which exacerbate with standing 89 and may improve when OI is treated. 90 Both delayed and rapid gastric emptying have been reported. 89 -92 OI has been identified in both younger and older case patients with cyclic vomiting syndrome, 93 with POTS present in 35% of adults. 93 -95 Symptoms and patterns of orthostatic HR and BP changes occur in adolescents with chronic fatigue syndrome and overlap with those of POTS. 96 -99 Headache, including migraine, is commonly reported in POTS and VVS. 100, 101 The association between headaches and OI has been primarily documented in adults. A few studies that include children have shown similar associations. 102 -104 In a study of adolescent headache patients in a tertiary-care setting, 53% had POTS. 105 Although headache can be a symptom of OI, the relationship is unclear. The treatment of POTS has been found to be only partially effective in relieving headache. 106 Sleep disorders, such as problematic sleep onset, maintenance, duration, quality, and daytime sleepiness, are consistently reported. 
ManageMenT
Although pharmacologic and nonpharmacologic interventions have not been compared, it is the opinion of the authors that nonpharmacologic interventions are more important to long-term outcomes, and they are therefore presented first.
nonpharmacologic Management

Fluids and Exercise
Cell dehydration causes adverse responses, including exaggerated cortisol response to exercise, decreased sympathetic nervous activity, and impaired cognitive and physical performance. 120 -123 Adequate daily water intake is defined by the National Academy of Medicine (formerly the Institute of Medicine) as 3.7 L for men and 3.0 L for women; however, euhydration is difficult to assess. 124 Bed rest emulates POTS with decreased stroke volume and increased HR to orthostasis, which occur in response to central hypovolemia. 125 Vigorous salt and water loading eliminates OH after bed rest. 126 Symptom severity negatively correlates with urinary sodium excretion. 127 Intravenous saline and salt improve symptoms in adolescents. 108 Large amounts of dietary salt improve symptoms in adults. 128 Some patients with POTS have deficits in plasma and blood volume without increased plasma renin or aldosterone but with increased angiotensin-II. 129, 130 Target salt and water intakes of 2.5 to 3 L daily in adolescent girls and 3.0 to 3.5 L daily in adolescent boys are recommended, which should be accompanied by >8 g sodium chloride daily. Glucose polymers (eg, maltodextrins) in commercial sports drinks are preferred. 131, 132 A goal is to achieve urine osmolality of <300 mmol/L or urine sodium >200 mmol per 24 hours. Intravenous hydration may be used acutely (eg, for gastrointestinal so-called influenza) but is strongly discouraged on a chronic basis.
Exercise Training
Four trials in young adults using HR as the target for exercise training showed efficacy in POTS. Exercise can expand blood volume by 20% to 25%. 133 
